Login / Signup
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
Britt Christensen
P R Gibson
D T Rubin
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
ulcerative colitis
multiple sclerosis
patients with inflammatory bowel disease
drug induced